Strategic Analysis of the Skin Biopsy Market, 2026–2035
The global Skin Biopsy Market was valued at USD 2.1 billion in 2025 and is estimated to reach USD 4 billion by the end of 2035, expanding at a CAGR of 6.3% during the forecast timeline. The market is experiencing steady growth due to the increasing prevalence of skin cancers, rising incidence of chronic dermatological disorders, growing awareness regarding early disease diagnosis, and continuous advancements in pathology and diagnostic technologies.
